account_id none on file
legal_name none on file
ticker VRNA
cik none on file
domain veronapharma.com
linkedin_company_url https://www.linkedin.com/company/verona-pharma-plc.
entry_point_account_id none on file
name Verona Pharma plc
sector Health Care
sector index/company/sector/health-care/
calls 2 filings 0 executives 3 family 0
why_nownone on file
calls
In addition, marketing and other commercial-related activities, including travel, increased by $7.5 million, and professional and consulting fees, information technology costs, and other related support costs, increased by $1.6 million, as we continue to build out our organization.
Nov 4, 2024 / receipt, needs a key / Mark Hahn, CFO | earnings call 2024-11-04 | transcript 681716b9-7bb0-4167-a66b-8d3b95556032 | chars 8447-8729 | segment 8
This increase was driven primarily by a $15.6 million increase in people-related costs as we expanded our headcount with key hires in medical affairs and commercial positions, inclusive of share-based compensation, as well as an increase of $9.7 million related to the build out of the commercial and information technology infrastructures, marketing and market development expenses, and costs associated with our medical affairs team's increased presence at local, regional, and national medical conferences.
Feb 29, 2024 / receipt, needs a key / Mark Hahn, CFO | earnings call 2024-02-29 | transcript 593e2f73-7df4-4796-8436-dc683ee35f57 | chars 9837-10346 | segment 9
filingsnone on file
executives
| David Zacardelli | CEO | - | receipt |
| David Zecardelli | CEO | - | receipt |
| Mark Hahn | CFO | - | receipt |
familynone on file
upcomingnone on file
changesnone on file
mcp_package_hint
slug verona-pharma-plc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$